Roivant Sciences Ltd. insider trading
This tab shows only the shares insiders bought or sold on the open market in the last twelve months (Form 4 codes P and S). Grants, option exercises, shares held back for tax and gifts are left out on purpose, so what is left is insiders trading at the market price like anyone else.
In the last twelve months insiders at Roivant Sciences Ltd. filed 119 open-market sales worth $894.2 million and 1 open-market purchase worth $350.0 million, on Form 4 with the SEC. The latest: Epperly Melissa B,, Director, sold 16,850 shares at $36.08 on 1 October 2026, filed 5 October 2026.
| Traded | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 1 October 2026 | Epperly Melissa B, | Director | Sale | 16,850 | $36.08 | $607,948 | Form 4 |
| 1 October 2026 | Epperly Melissa B, | Director | Sale | 900 | $36.57 | $32,913 | Form 4 |
| 30 September 2026 | Venker Eric | President & Immunovant CEO | Sale | 200,000 | $36.62 | $7.3 million | Form 4 |
| 15 September 2026 | Epperly Melissa B, | Director | Sale | 4,338 | $39.65 | $172,002 | Form 4 |
| 15 September 2026 | Epperly Melissa B, | Director | Sale | 600 | $40.38 | $24,228 | Form 4 |
| 15 September 2026 | Fitzgerald Meghan | Director | Sale | 4,712 | $39.68 | $186,972 | Form 4 |
| 15 September 2026 | Fitzgerald Meghan | Director | Sale | 400 | $40.45 | $16,180 | Form 4 |
| 8 September 2026 | Fitzgerald Meghan | Director | Sale | 20,000 | $39.90 | $798,000 | Form 4 |
| 28 August 2026 | Venker Eric | President & Immunovant CEO | Sale | 166,182 | $35.63 | $5.9 million | Form 4 |
| 28 August 2026 | Venker Eric | President & Immunovant CEO | Sale | 33,818 | $36.44 | $1.2 million | Form 4 |
| 21 August 2026 | Sukhatme Mayukh | President & CIO | Sale | 144,756 | $36.48 | $5.3 million | Form 4 |
| 20 August 2026 | Sukhatme Mayukh | President & CIO | Sale | 17,519 | $37.30 | $653,459 | Form 4 |
| 19 August 2026 | Sukhatme Mayukh | President & CIO | Sale | 172,899 | $37.17 | $6.4 million | Form 4 |
| 18 August 2026 | Sukhatme Mayukh | President & CIO | Sale | 105,141 | $36.59 | $3.8 million | Form 4 |
| 18 August 2026 | Sukhatme Mayukh | President & CIO | Sale | 31,801 | $37.18 | $1.2 million | Form 4 |
| 17 August 2026 | Sukhatme Mayukh | President & CIO | Sale | 284,707 | $36.25 | $10.3 million | Form 4 |
| 14 August 2026 | Sukhatme Mayukh | President & CIO | Sale | 243,177 | $36.23 | $8.8 million | Form 4 |
| 27 July 2026 | Venker Eric | President & Immunovant CEO | Sale | 200,000 | $34.95 | $7.0 million | Form 4 |
| 30 June 2026 | Fitzgerald Meghan | Director | Sale | 10,000 | $34.90 | $349,000 | Form 4 |
| 29 June 2026 | Epperly Melissa B, | Director | Sale | 15,002 | $34.32 | $514,869 | Form 4 |
| 29 June 2026 | Epperly Melissa B, | Director | Sale | 2,748 | $34.71 | $95,383 | Form 4 |
| 30 June 2026 | Manchester Keith S | Director | Sale | 12,380 | $35.28 | $436,766 | Form 4 |
| 30 June 2026 | Manchester Keith S | Director | Sale | 200,000 | $35.45 | $7.1 million | Form 4 |
| 30 June 2026 | Gold Daniel Allen | Director | Sale | 12,380 | $35.28 | $436,766 | Form 4 |
| 30 June 2026 | Qvt Financial Lp | Insider | Sale | 12,380 | $35.28 | $436,766 | Form 4 |
| 29 June 2026 | Manchester Keith S | Director | Sale | 200,000 | $34.44 | $6.9 million | Form 4 |
| 29 June 2026 | Manchester Keith S | Director | Sale | 600,000 | $34.59 | $20.8 million | Form 4 |
| 29 June 2026 | Gold Daniel Allen | Director | Sale | 200,000 | $34.44 | $6.9 million | Form 4 |
| 29 June 2026 | Gold Daniel Allen | Director | Sale | 600,000 | $34.59 | $20.8 million | Form 4 |
| 29 June 2026 | Qvt Financial Lp | Insider | Sale | 200,000 | $34.44 | $6.9 million | Form 4 |
| 29 June 2026 | Qvt Financial Lp | Insider | Sale | 600,000 | $34.59 | $20.8 million | Form 4 |
| 26 June 2026 | Manchester Keith S | Director | Sale | 300,783 | $33.92 | $10.2 million | Form 4 |
| 26 June 2026 | Manchester Keith S | Director | Sale | 325,000 | $34.07 | $11.1 million | Form 4 |
| 26 June 2026 | Gold Daniel Allen | Director | Sale | 300,783 | $33.92 | $10.2 million | Form 4 |
| 26 June 2026 | Gold Daniel Allen | Director | Sale | 325,000 | $34.07 | $11.1 million | Form 4 |
| 26 June 2026 | Qvt Financial Lp | Insider | Sale | 300,783 | $33.92 | $10.2 million | Form 4 |
| 26 June 2026 | Qvt Financial Lp | Insider | Sale | 325,000 | $34.07 | $11.1 million | Form 4 |
| 26 June 2026 | Sukhatme Mayukh | President & CIO | Sale | 500,000 | $34.08 | $17.0 million | Form 4 |
| 25 June 2026 | Sukhatme Mayukh | President & CIO | Sale | 500,000 | $34.13 | $17.1 million | Form 4 |
| 24 June 2026 | Venker Eric | President & Immunovant CEO | Sale | 153,766 | $33.05 | $5.1 million | Form 4 |
| 24 June 2026 | Venker Eric | President & Immunovant CEO | Sale | 46,234 | $33.51 | $1.5 million | Form 4 |
| 22 May 2026 | Venker Eric | President & Immunovant CEO | Sale | 200,000 | $30.27 | $6.1 million | Form 4 |
| 20 April 2026 | Venker Eric | President & Immunovant CEO | Sale | 200,000 | $29.59 | $5.9 million | Form 4 |
| 16 April 2026 | Gline Matthew | CEO | Sale | 289,774 | $29.16 | $8.4 million | Form 4 |
| 8 April 2026 | Humes Jennifer | Chief Accounting Officer | Sale | 13,538 | $28.37 | $384,073 | Form 4 |
| 26 March 2026 | Fitzgerald Meghan | Director | Sale | 70,000 | $27.45 | $1.9 million | Form 4 |
| 17 March 2026 | Venker Eric | President & Immunovant CEO | Sale | 200,000 | $28.24 | $5.6 million | Form 4 |
| 16 March 2026 | Epperly Melissa B, | Director | Sale | 41,861 | $28.68 | $1.2 million | Form 4 |
| 23 February 2026 | Torti Frank | President and Vant Chair | Sale | 587,390 | $27.51 | $16.2 million | Form 4 |
| 20 February 2026 | Torti Frank | President and Vant Chair | Sale | 1,012,610 | $27.15 | $27.5 million | Form 4 |
| 19 February 2026 | Torti Frank | President and Vant Chair | Sale | 1,400,000 | $27.42 | $38.4 million | Form 4 |
| 13 February 2026 | Venker Eric | President & Immunovant CEO | Sale | 200,000 | $26.49 | $5.3 million | Form 4 |
| 13 February 2026 | Manchester Keith S | Director | Sale | 150,784 | $26.49 | $4.0 million | Form 4 |
| 13 February 2026 | Manchester Keith S | Director | Sale | 225,000 | $26.50 | $6.0 million | Form 4 |
| 13 February 2026 | Gold Daniel Allen | Director | Sale | 150,784 | $26.49 | $4.0 million | Form 4 |
| 13 February 2026 | Gold Daniel Allen | Director | Sale | 225,000 | $26.50 | $6.0 million | Form 4 |
| 13 February 2026 | Qvt Financial Lp | Insider | Sale | 150,784 | $26.49 | $4.0 million | Form 4 |
| 13 February 2026 | Qvt Financial Lp | Insider | Sale | 225,000 | $26.50 | $6.0 million | Form 4 |
| 12 February 2026 | Manchester Keith S | Director | Sale | 150,000 | $26.72 | $4.0 million | Form 4 |
| 12 February 2026 | Manchester Keith S | Director | Sale | 275,000 | $26.76 | $7.4 million | Form 4 |
| 12 February 2026 | Gold Daniel Allen | Director | Sale | 150,000 | $26.72 | $4.0 million | Form 4 |
| 12 February 2026 | Gold Daniel Allen | Director | Sale | 275,000 | $26.76 | $7.4 million | Form 4 |
| 12 February 2026 | Qvt Financial Lp | Insider | Sale | 150,000 | $26.72 | $4.0 million | Form 4 |
| 12 February 2026 | Qvt Financial Lp | Insider | Sale | 275,000 | $26.76 | $7.4 million | Form 4 |
| 11 February 2026 | Manchester Keith S | Director | Sale | 425,000 | $26.67 | $11.3 million | Form 4 |
| 11 February 2026 | Gold Daniel Allen | Director | Sale | 425,000 | $26.67 | $11.3 million | Form 4 |
| 11 February 2026 | Qvt Financial Lp | Insider | Sale | 425,000 | $26.67 | $11.3 million | Form 4 |
| 9 February 2026 | Sukhatme Mayukh | President & CIO | Sale | 339,441 | $26.47 | $9.0 million | Form 4 |
| 12 January 2026 | Venker Eric | President & Immunovant CEO | Sale | 200,000 | $21.92 | $4.4 million | Form 4 |
| 31 December 2025 | Sukhatme Mayukh | President & CIO | Sale | 1,018,995 | $21.71 | $22.1 million | Form 4 |
| 29 December 2025 | Sukhatme Mayukh | President & CIO | Sale | 311,873 | $21.74 | $6.8 million | Form 4 |
| 24 December 2025 | Venker Eric | President & Immunovant CEO | Sale | 75,000 | $22.53 | $1.7 million | Form 4 |
| 23 December 2025 | Pulik Richard | CFO | Sale | 260,000 | $22.45 | $5.8 million | Form 4 |
| 23 December 2025 | Pulik Richard | CFO | Sale | 146,731 | $22.39 | $3.3 million | Form 4 |
| 23 December 2025 | Venker Eric | President & Immunovant CEO | Sale | 200,000 | $22.45 | $4.5 million | Form 4 |
| 17 December 2025 | Sukhatme Mayukh | President & CIO | Sale | 26,831 | $23.09 | $619,528 | Form 4 |
| 17 December 2025 | Gold Daniel Allen | Director | Sale | 432,718 | $23.05 | $10.0 million | Form 4 |
| 17 December 2025 | Gold Daniel Allen | Director | Sale | 155,076 | $23.02 | $3.6 million | Form 4 |
| 17 December 2025 | Gold Daniel Allen | Director | Sale | 189,538 | $23.17 | $4.4 million | Form 4 |
| 17 December 2025 | Manchester Keith S | Director | Sale | 432,718 | $23.05 | $10.0 million | Form 4 |
| 17 December 2025 | Manchester Keith S | Director | Sale | 155,076 | $23.02 | $3.6 million | Form 4 |
| 17 December 2025 | Manchester Keith S | Director | Sale | 189,538 | $23.17 | $4.4 million | Form 4 |
| 17 December 2025 | Qvt Financial Lp | Insider | Sale | 432,718 | $23.05 | $10.0 million | Form 4 |
| 17 December 2025 | Qvt Financial Lp | Insider | Sale | 155,076 | $23.02 | $3.6 million | Form 4 |
| 17 December 2025 | Qvt Financial Lp | Insider | Sale | 189,538 | $23.17 | $4.4 million | Form 4 |
| 16 December 2025 | Gold Daniel Allen | Director | Sale | 275,000 | $22.93 | $6.3 million | Form 4 |
| 16 December 2025 | Gold Daniel Allen | Director | Sale | 642,282 | $23.08 | $14.8 million | Form 4 |
| 16 December 2025 | Manchester Keith S | Director | Sale | 275,000 | $22.93 | $6.3 million | Form 4 |
| 16 December 2025 | Manchester Keith S | Director | Sale | 642,282 | $23.08 | $14.8 million | Form 4 |
| 16 December 2025 | Qvt Financial Lp | Insider | Sale | 275,000 | $22.93 | $6.3 million | Form 4 |
| 16 December 2025 | Qvt Financial Lp | Insider | Sale | 642,282 | $23.08 | $14.8 million | Form 4 |
| 15 December 2025 | Gline Matthew | CEO | Sale | 230,357 | $21.68 | $5.0 million | Form 4 |
| 15 December 2025 | Gline Matthew | CEO | Sale | 566,116 | $21.68 | $12.3 million | Form 4 |
| 15 December 2025 | Gline Matthew | CEO | Sale | 943,527 | $21.68 | $20.5 million | Form 4 |
| 15 December 2025 | Ramaswamy Vivek | 10% owner | Sale | 353,745 | $22.05 | $7.8 million | Form 4 |
| 12 December 2025 | Ramaswamy Vivek | 10% owner | Sale | 1,975,858 | $21.96 | $43.4 million | Form 4 |
| 11 December 2025 | Ramaswamy Vivek | 10% owner | Sale | 774,142 | $21.64 | $16.8 million | Form 4 |
| 12 December 2025 | Roivant Sciences Ltd. | Director | Purchase | 16,666,666 | $21.00 | $350.0 million | Form 4 |
| 9 December 2025 | Venker Eric | President & Immunovant CEO | Sale | 200,000 | $20.85 | $4.2 million | Form 4 |
| 19 November 2025 | Manchester Keith S | Director | Sale | 850,000 | $20.25 | $17.2 million | Form 4 |
| 19 November 2025 | Manchester Keith S | Director | Sale | 150,000 | $20.20 | $3.0 million | Form 4 |
| 19 November 2025 | Manchester Keith S | Director | Sale | 125,000 | $20.16 | $2.5 million | Form 4 |
| 19 November 2025 | Manchester Keith S | Director | Sale | 175,000 | $20.24 | $3.5 million | Form 4 |
| 19 November 2025 | Gold Daniel Allen | Director | Sale | 850,000 | $20.25 | $17.2 million | Form 4 |
| 19 November 2025 | Gold Daniel Allen | Director | Sale | 150,000 | $20.20 | $3.0 million | Form 4 |
| 19 November 2025 | Gold Daniel Allen | Director | Sale | 125,000 | $20.16 | $2.5 million | Form 4 |
| 19 November 2025 | Gold Daniel Allen | Director | Sale | 175,000 | $20.24 | $3.5 million | Form 4 |
| 19 November 2025 | Qvt Financial Lp | Insider | Sale | 850,000 | $20.25 | $17.2 million | Form 4 |
| 19 November 2025 | Qvt Financial Lp | Insider | Sale | 150,000 | $20.20 | $3.0 million | Form 4 |
| 19 November 2025 | Qvt Financial Lp | Insider | Sale | 125,000 | $20.16 | $2.5 million | Form 4 |
| 19 November 2025 | Qvt Financial Lp | Insider | Sale | 175,000 | $20.24 | $3.5 million | Form 4 |
| 17 November 2025 | Ramaswamy Vivek | 10% owner | Sale | 539,650 | $20.51 | $11.1 million | Form 4 |
| 14 November 2025 | Ramaswamy Vivek | 10% owner | Sale | 1,027,670 | $20.33 | $20.9 million | Form 4 |
| 13 November 2025 | Ramaswamy Vivek | 10% owner | Sale | 287,283 | $20.81 | $6.0 million | Form 4 |
| 7 November 2025 | Venker Eric | President & Immunovant CEO | Sale | 200,000 | $20.22 | $4.0 million | Form 4 |
| 17 October 2025 | Venker Eric | President & Immunovant CEO | Sale | 118,418 | $17.06 | $2.0 million | Form 4 |
| 16 October 2025 | Venker Eric | President & Immunovant CEO | Sale | 318,282 | $17.05 | $5.4 million | Form 4 |
| 15 October 2025 | Venker Eric | President & Immunovant CEO | Sale | 414,683 | $16.93 | $7.0 million | Form 4 |
| 13 October 2025 | Venker Eric | President & Immunovant CEO | Sale | 20,727 | $16.25 | $336,814 | Form 4 |
| 9 October 2025 | Venker Eric | President & Immunovant CEO | Sale | 104,940 | $16.30 | $1.7 million | Form 4 |
A filing with several lines appears once per line.
Source
Form 4 filings on EDGAR for Roivant Sciences Ltd.: the company's filing index.
The same record on your computer
GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.